SFR / Medicen / SNITEM Award
Three Inria startups are finalists for the SFR/Medicen/SNITEM Prize
The SFR/Medicen/SNITEM prize supporting new, innovative companies in diagnostic and interventional medical imaging will be awarded at the 65th edition of the French Days of Radiology Congress (JFR). Three Inria startups are among the six finalists.
The Société Française de Radiologie (SFR), Medicen Paris Région and Syndicat National de l’Industrie des Technologies Médicales (SNITEM) wish to support the activity and development of innovative startups in the field of medical imaging. The six finalists for the SFR/Medicen/SNITEM prize were announced leading up to the 2017 edition of the JFR Congress: Three Inria startups - InHeart, Therapanacea and Therapixel - are among the lucky finalists, along with three other startups: Basecamp Vascular, Imageens and Statlife.
Already a winner of the i-LAB 2017 contest to support the creation of innovative technology companies (Bpifrance and the French Ministry of Higher Education, Research and innovation) and the Innovation Journey 2017 by EIT Health, InHeart proposes a service that transforms patient scanner and MRI images into virtual, personalized hearts. The result, integrated into existing interventional environments, provides cardiologists with a 3D visualization of their instruments in real time. This allows for safer, simpler, shorter and more effective treatment thanks to direct visualization. The personalized imaging approach should make it possible to improve results and allow for wider spread usage. The solution may be used for treating ventricular tachycardia that causes sudden death, atrial fibrillation or even for selecting patients prior to pacemaker or defibrillator implant.
Also a winner of i-LAB 2017, the startup Therapanacea falls somewhere between applied mathematics and artificial intelligence. Their TheraAdaptRT solution introduces recalculation of the radiation plan in real time, taking the patient’s anatomy into consideration. The result is the development of intelligent digital tools in the form of a new software component specific to adaptive radiotherapy. By optimizing the chain of treatment, the solution could notably enable twice as many patients to be treated, while still increasing their safety and chances of survival.
Therapixel is a startup devoted to publishing medical imaging software that was co-founded in 2013 by two Inria researchers: Olivier Clatz and Pierre Fillard. Winner of i-LAB 2013, and NETVA 2016, Therapixel changed course at the start of 2016 to focus on artificial intelligence and develop a new activity to aid in interpreting medical images. Their objective? Revolutionize diagnostic radiology using algorithms with performance levels comparable to those of the best experts in the field.